MarketResearchReports.Biz
presents this most up-to-date research on " Systemic Lupus
Erythematosus Global Clinical Trials Review, H2, 2016 "
GlobalData's clinical trial
report,
Systemic Lupus Erythematosus
Global Clinical Trials Review, H2, 2016" provides an overview of
Systemic Lupus Erythematosus clinical trials scenario. This report
provides top line data relating to the clinical trials on Systemic
Lupus Erythematosus. Report includes an overview of trial numbers and
their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region,
country (G7 & E7), phase, trial status, end points status and
sponsor type. Report also provides prominent drugs for in-progress
trials (based on number of ongoing trials). GlobalData Clinical Trial
Reports are generated using GlobalDatas proprietary database - Pharma
eTrack Clinical trials database. Clinical trials are collated from
80+ different clinical trial registries, conferences, journals, news
etc across the globe. Clinical trials database undergoes periodic
update by dynamic process.
The report enhances the
decision making capabilities and helps to create an effective counter
strategies to gain competitive advantage.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/841041
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons
to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing
to Clinical Trials in Europe 11
Top Countries Contributing to
Clinical Trials in North America 12
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing
to Clinical Trials in Central and South America 14
Clinical Trials by G7
Countries: Proportion of Systemic Lupus Erythematosus to Immunology
Clinical Trials 15
Clinical Trials by Phase in G7
Countries 16
Clinical Trials in G7 Countries
by Trial Status 17
Clinical Trials by E7
Countries: Proportion of Systemic Lupus Erythematosus to Immunology
Clinical Trials 18
Clinical Trials by Phase in E7
Countries 19
Clinical Trials in E7 Countries
by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status
23
Clinical Trials by End Point
Status 24
Subjects Recruited Over a
Period of Time 25
Clinical Trials by Sponsor Type
26
Prominent Sponsors 27
Top Companies Participating in
Systemic Lupus Erythematosus Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on
Systemic Lupus Erythematosus 31
Aug 03, 2016: Anthera
Pharmaceuticals Announces Completion of Dosing in CHABLIS-SC1 Phase 3
Clinical Study with Blisibimod 31
Jul 19, 2016: Kadmon Data
Published in Science Signaling Show ROCK2 Signaling as a Key
Modulator of T Follicular Helper Cell Function in Autoimmune Diseases
31
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment